Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

Alterations in Muscle Tone lll

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Xanthophylls: potential benefits in protecting against UV burns.

Brazilian journal of biology = Revista brasleira de biologia·2025

Same author

Potential of marine compounds in the treatment of neurodegenerative diseases: a review.

Brazilian journal of biology = Revista brasleira de biologia·2023

Same author

Mild-to-moderate COVID-19 impact on the cardiorespiratory fitness in young and middle-aged populations.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2022

Same author

Differential protein expression in diverse brain areas of Parkinson's and Alzheimer's disease patients.

Scientific reports·2020

Same author

Added sugar and trans fatty acid intake and sedentary behavior were associated with excess total-body and central adiposity in children and adolescents with congenital heart disease.

Pediatric obesity·2020

Same author

The mediational role of distracting stimuli in emotional word recognition.

Psicologia, reflexao e critica : revista semestral do Departamento de Psicologia da UFRGS·2020

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Published on: June 23, 2023

Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD.

A R Esteves¹, D M Arduíno, D F F Silva

¹Centro de Neurociências e Biologia Celular, Universidade de Coimbra, 3004 Coimbra, Portugal.

Parkinson'S Disease

|February 15, 2011

Summary

Mitochondrial dysfunction precedes Parkinson's disease symptoms, impacting alpha-synuclein aggregation. Restoring microtubule networks offers a novel therapeutic approach for Parkinson's disease.

More Related Videos

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Published on: June 30, 2023

Related Experiment Videos

Last Updated: Jun 4, 2026

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Published on: June 23, 2023

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Published on: June 30, 2023

Area of Science:

Neuroscience
Cell Biology
Biochemistry

Background:

Mitochondrial dysfunction is increasingly implicated in Parkinson's disease (PD) pathogenesis.
Mitochondria regulate critical cellular processes including energy metabolism, calcium homeostasis, and cell death.
Alpha-synuclein aggregation is a hallmark of Parkinson's disease.

Purpose of the Study:

To explore the role of mitochondrial dysfunction in alpha-synuclein aggregation in Parkinson's disease.
To investigate the link between mitochondrial metabolism, microtubule function, and autophagic pathways in PD.

Main Methods:

Review of existing literature on mitochondrial dysfunction and Parkinson's disease.
Analysis of the interplay between mitochondrial regulation, microtubule dynamics, and protein degradation.

Main Results:

Mitochondrial dysfunction is a key early event in Parkinson's disease.
Mitochondria regulate microtubule-dependent transport and the autophagic-lysosomal pathway.
Impaired microtubule function contributes to the accumulation of aggregated alpha-synuclein.

Conclusions:

Mitochondrial dysfunction drives alpha-synuclein aggregation in Parkinson's disease.
Alterations in microtubule networks lead to autophagic deficiency and protein aggregate buildup.
Targeting microtubule restoration presents a promising therapeutic strategy for Parkinson's disease.